bluebird bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
bluebird bio (Nasdaq: BLUE) has announced an inducement grant of stock options to its new controller and vice president of accounting, Joe Ewer. The Compensation Committee approved options to purchase 38,200 shares of common stock, with a grant date of August 1, 2024. The options have an exercise price of $1.08 per share, equal to the fair market value on the grant date. These options vest over four years, with 25% vesting after one year and the remainder vesting monthly. The options have a 10-year term and were granted as an inducement for Mr. Ewer's employment, in accordance with NASDAQ Listing Rule 5635(c)(4).
bluebird bio (Nasdaq: BLUE) ha annunciato un'assegnazione di opzioni su azioni come incentivo per il suo nuovo controller e vicepresidente della contabilità, Joe Ewer. Il Comitato per la Compensazione ha approvato opzioni per acquistare 38.200 azioni di azioni ordinarie, con data di assegnazione del 1 agosto 2024. Le opzioni hanno un prezzo di esercizio di $1.08 per azione, pari al valore equo di mercato alla data di assegnazione. Queste opzioni si maturano in quattro anni, con un 25% che si matura dopo un anno e il resto che matura mensilmente. Le opzioni hanno un termine di 10 anni e sono state concesse come incentivo per l'impiego del signor Ewer, in conformità con la Regola di Quotazione NASDAQ 5635(c)(4).
bluebird bio (Nasdaq: BLUE) ha anunciado una concesión de opciones sobre acciones como incentivo para su nuevo controlador y vicepresidente de contabilidad, Joe Ewer. El Comité de Compensación aprobó opciones para comprar 38,200 acciones de acciones ordinarias, con fecha de concesión del 1 de agosto de 2024. Las opciones tienen un precio de ejercicio de $1.08 por acción, igual al valor justo de mercado en la fecha de concesión. Estas opciones se consolidan durante cuatro años, con un 25% que se consolida después de un año y el resto consolidándose mensualmente. Las opciones tienen un plazo de 10 años y se otorgaron como incentivo para el empleo del Sr. Ewer, de acuerdo con la Regla de Cotización NASDAQ 5635(c)(4).
bluebird bio (Nasdaq: BLUE)는 새로운 제어자 겸 회계 부사장인 Joe Ewer에게 주식 옵션을 유인 보상으로 수여한다고 발표했습니다. 보상 위원회는 38,200주의 보통주를 구매할 수 있는 옵션을 승인했으며, 부여일은 2024년 8월 1일입니다. 옵션의 행사 가격은 주당 $1.08으로, 부여일의 공정 시장 가치와 동일합니다. 이 옵션은 4년에 걸쳐 분할 지급됩니다, 1년 후에 25%가 분할되고 나머지는 매달 분할 지급됩니다. 이 옵션은 10년의 유효기간을 가지며, Ewer 씨의 고용을 위한 유인으로 제공되었습니다. 이는 NASDAQ 상장 규칙 5635(c)(4)에 따른 것입니다.
bluebird bio (Nasdaq: BLUE) a annoncé une attribution d'options d'achat d'actions en tant qu'incitation pour son nouveau contrôleur et vice-président de la comptabilité, Joe Ewer. Le Comité de Rémunération a approuvé des options pour acheter 38 200 actions ordinaires, avec une date d'attribution du 1er août 2024. Les options ont un prix d'exercice de 1,08 $ par action, équivalent à la juste valeur marchande à la date d'attribution. Ces options s'acquièrent sur quatre ans, avec 25 % des options devenant accessibles après un an et le reste devenant accessible mensuellement. Les options ont un terme de 10 ans et ont été accordées comme incitation à l'emploi de M. Ewer, conformément à la Règle de Cotation NASDAQ 5635(c)(4).
bluebird bio (Nasdaq: BLUE) hat eine Zuteilung von Aktienoptionen als Anreiz für seinen neuen Controller und Finanzvicepräsidenten Joe Ewer angekündigt. Der Vergütungsausschuss genehmigte Optionen zum Kauf von 38.200 Aktien zum Datum der Zuteilung am 1. August 2024. Die Optionen haben einen Ausübungspreis von $1,08 pro Aktie, was dem fairen Marktwert am Zuteilungsdatum entspricht. Diese Optionen werden über vier Jahre erworben, wobei 25 % nach einem Jahr erworben werden und der Rest monatlich erworben wird. Die Optionen haben eine Laufzeit von 10 Jahren und wurden als Anreiz für die Beschäftigung von Herrn Ewer gemäß NASDAQ-Listing-Regel 5635(c)(4) gewährt.
- Attraction of new talent with Joe Ewer joining as controller and VP of accounting
- Alignment of executive interests with shareholders through stock option grants
- Potential dilution of existing shareholders due to new stock option issuance
The stock options approved under the Inducement Plan have an exercise price per share equal to
The Company granted the stock options as inducement materials to Joe Ewer entering into employment with bluebird bio, Inc. in accordance with NASDAQ Listing Rule 5635(c)(4).
About bluebird bio, Inc.
bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.
Founded in 2010, bluebird has been setting the standard for gene therapy for more than a decade—first as a scientific pioneer and now as a commercial leader. bluebird has an unrivaled track record in bringing the promise of gene therapy out of clinical studies and into the real-world setting, having secured FDA approvals for three therapies in under two years. Today, we are proving and scaling the commercial model for gene therapy and delivering innovative solutions for access to patients, providers, and payers.
With a dedicated focus on severe genetic diseases, bluebird has the largest and deepest ex-vivo gene therapy data set in the field, with industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward.
bluebird continues to forge new paths as a standalone commercial gene therapy company, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240802449243/en/
Investors:
Courtney O’Leary, 978-621-7347
coleary@bluebirdbio.com
Media:
Jess Rowlands, 857-299-6103
jess.rowlands@bluebirdbio.com
Source: bluebird bio, Inc.
FAQ
How many stock options did bluebird bio (BLUE) grant to Joe Ewer?
What is the exercise price of the stock options granted by bluebird bio (BLUE)?
When do the stock options granted by bluebird bio (BLUE) vest?
What position did Joe Ewer take at bluebird bio (BLUE)?
